Acadia Pharmaceuticals | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
ALKERMES USD 2.08B 26.41M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Corcept Therapeutics USD 846.46M 5.9M 2025-03
Cytokinetics USD 1.26B 137.62M 2025-03
Eisai JPY 1.39T 46.32B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Incyte USD 5.75B 305.04M 2025-03
J&J USD 193.67B 13.57B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Prothena USD 547.11M 48.15M 2024-12
PTC Therapeutics USD 2.66B 950.36M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Acadia Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.